Clinical Trial Update: An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating Tc-99m tilmanocept given intravenously and subcutaneously in Kaposi sarcoma patients (including individuals with HIV infection); result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Kaposi Sarcoma

Drugs mentioned

• Lymphoseek (tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Kaposi Sarcoma, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2025-03-05